Robert J Hariri Cryoport, Inc. (CYRX) insider trading activity

Robert J Hariri is Director of Cryoport, Inc.. Currently has a direct ownership of 51,275 shares of CYRX, which is worth approximately $444,554. The most recent transaction as insider was on Sep 11, 2025, when has been sold 25,000 shares (Common Stock) at a price of $9.71 per share, resulting in proceeds of $242,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.3K

0% 3M change

149.38% 12M change

Total Value Held $444,554

Robert J Hariri Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 11 2025	SELL Open market or private sale	$242,750 $9.71 p/Share	25,000 Reduced 32.78%	51,275 Common Stock
Sep 11 2025	BUY Exercise of conversion of derivative security	$133,000 $2.66 p/Share	50,000 Added 39.6%	76,275 Common Stock
Aug 22 2025	SELL Open market or private sale	$43,000 $8.6 p/Share	5,000 Reduced 15.99%	26,275 Common Stock
Jun 06 2025	BUY Grant, award, or other acquisition	-	23,214 Added 42.6%	31,275 Common Stock
May 28 2025	SELL Open market or private sale	$76,250 $6.1 p/Share	12,500 Reduced 60.79%	8,061 Common Stock
Nov 21 2024	SELL Open market or private sale	$16,200 $6.48 p/Share	2,500 Reduced 10.84%	20,561 Common Stock
Aug 19 2024	SELL Open market or private sale	$9,460 $9.46 p/Share	1,000 Reduced 4.16%	23,061 Common Stock

Aug 16 2024	SELL Open market or private sale	$9,000 $9.0 p/Share	1,000 Reduced 4.07%	23,561 Common Stock
Aug 14 2024	SELL Open market or private sale	$8,400 $8.4 p/Share	1,000 Reduced 3.91%	24,561 Common Stock
May 17 2024	BUY Grant, award, or other acquisition	-	12,845 Added 33.45%	25,561 Common Stock
Dec 14 2023	SELL Open market or private sale	$13,512 $16.89 p/Share	800 Reduced 5.92%	12,716 Common Stock
Dec 11 2023	SELL Open market or private sale	$15,500 $15.5 p/Share	1,000 Reduced 6.89%	13,516 Common Stock
Sep 06 2023	SELL Open market or private sale	$20,400 $13.6 p/Share	1,500 Reduced 9.37%	14,516 Common Stock
May 12 2023	BUY Grant, award, or other acquisition	-	8,105 Added 33.6%	16,016 Common Stock
Aug 11 2022	SELL Open market or private sale	$86,580 $43.29 p/Share	2,000 Reduced 20.18%	7,911 Common Stock
Apr 30 2022	BUY Exercise of conversion of derivative security	-	2,708 Added 21.46%	9,911 Common Stock
Apr 29 2022	BUY Grant, award, or other acquisition	-	7,203 Added 50.0%	7,203 Common Stock

Also insider at

CELU

Celularity Inc Healthcare

Chief Executive Officer

BIVI

BIOVIE INC. Healthcare

Director

RJH

Robert J Hariri

Director

Brentwood, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYRX shares.

Notify only if

Value

Insider Trading

Get notified when an Cryoport, Inc. insider buys or sells CYRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cryoport, Inc.

Track Activities on CYRX

Account